PEPG Insider Trading

Insider Ownership Percentage: 4.60%
Insider Buying (Last 12 Months): $27,219,853.50
Insider Selling (Last 12 Months): $844,268.77

PepGen Insider Trading History Chart

This chart shows the insider buying and selling history at PepGen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PepGen Share Price & Price History

Current Price: $9.26
Price Change: Price Increase of +0.14 (1.54%)
As of 09/18/2024 01:00 AM ET

This chart shows the closing price history over time for PEPG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

PepGen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/25/2024Michelle L. MellioninsiderSell7,571$18.06$136,732.26View SEC Filing Icon  
7/18/2024Michelle L. MellioninsiderSell12,625$18.20$229,775.00View SEC Filing Icon  
7/16/2024Michelle L. MellioninsiderSell5,901$18.00$106,218.00View SEC Filing Icon  
7/12/2024Michelle L. MellioninsiderSell3,288$18.04$59,315.52View SEC Filing Icon  
7/2/2024Michelle L. MellioninsiderSell37$18.07$668.59View SEC Filing Icon  
6/24/2024Michelle L. MellioninsiderSell9,260$18.19$168,439.40View SEC Filing Icon  
6/11/2024Michelle L. MellioninsiderSell500$18.04$9,020.00View SEC Filing Icon  
5/17/2024Niels SvenstrupSVPSell10,000$13.41$134,100.00View SEC Filing Icon  
2/9/2024Ra Capital Management, L.P.DirectorBuy2,557,593$10.64$27,212,789.529,179,273View SEC Filing Icon  
11/30/2023James G McarthurCEOBuy1,694$4.17$7,063.981,694View SEC Filing Icon  
6/7/2023James G. McarthurCEOSell8,419$16.23$136,640.37View SEC Filing Icon  
6/5/2023James G. McarthurCEOSell500$16.06$8,030.00View SEC Filing Icon  
6/2/2023James G. McarthurCEOSell1,800$16.04$28,872.00View SEC Filing Icon  
3/24/2023Jaya GoyalEVPSell392$20.00$7,840.00View SEC Filing Icon  
2/8/2023Jaya GoyalEVPSell644$17.00$10,948.00View SEC Filing Icon  
2/6/2023Jaya GoyalEVPSell1,677$17.04$28,576.08View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for PepGen (NASDAQ:PEPG)

58.01% of PepGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PEPG by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

PepGen Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/16/2024Point72 DIFC Ltd2,621$42K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.145,174$2.32M0.0%-24.5%0.448%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd2,621$42K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP12,251$0.20M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/10/2024Sofinnova Investments Inc.561,128$8.96M0.5%+11.4%1.731%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC12,000$0.19M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.20,028$0.32M0.0%+19.9%0.062%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers18,853$0.30M0.0%+36.1%0.058%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp44,157$0.71M0.0%+43.6%0.136%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.10,689,545$157.14M2.0%+31.5%32.972%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.200,000$2.94M0.1%N/A0.617%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC1,166,642$17.23M0.0%+18.1%3.602%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC2,052$30K0.0%N/A0.006%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.850,445$12.50M0.0%+68.0%2.626%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.680,000$3.45M0.0%+18.3%2.856%Search for SEC Filing on Google Icon
11/13/2023Rathbones Group PLC62,003$0.32M0.0%N/A0.260%Search for SEC Filing on Google Icon
11/13/2023FMR LLC2,365,965$12.02M0.0%-13.8%9.937%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC6,564$33K0.0%N/A0.028%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp31,398$0.16M0.0%-15.0%0.132%Search for SEC Filing on Google Icon
8/15/2023Suvretta Capital Management LLC486,611$4.35M0.2%-41.2%2.044%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.4,837$43K0.0%-33.3%0.020%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can199,532$2.66M0.0%N/A0.839%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC8,647$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/15/2022Parkman Healthcare Partners LLC100,000$0.91M0.3%N/A0.423%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al220,530$1.57M0.0%-24.2%0.933%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP40,000$0.36M0.1%-50.0%0.169%Search for SEC Filing on Google Icon
8/16/2022Deerfield Management Company L.P. Series C953,626$9.47M0.2%N/A4.036%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP664,516$6.60M0.1%N/A2.812%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
PepGen logo
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.
Read More on PepGen

Today's Range

Now: $9.26
Low: $8.96
High: $9.67

50 Day Range

MA: $11.55
Low: $7.75
High: $18.55

52 Week Range

Now: $9.26
Low: $3.72
High: $19.30

Volume

53,256 shs

Average Volume

126,061 shs

Market Capitalization

$301.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of PepGen?

PepGen's top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. James G Mcarthur (CEO)
  3. James G Mcarthur (CEO)
  4. Jaya Goyal (EVP)
  5. Michelle L Mellion (Insider)
  6. Niels Svenstrup (SVP)
Learn More about top insider investors at PepGen.

Who are the major institutional investors of PepGen?

PepGen's top institutional investors include:
  1. Sofinnova Investments Inc. — 1.73%
  2. Point72 Asset Management L.P. — 0.45%
  3. Bank of New York Mellon Corp — 0.14%
  4. American Century Companies Inc. — 0.06%
  5. Rhumbline Advisers — 0.06%
  6. Marshall Wace LLP — 0.04%
Learn More about top institutional investors of PepGen stock.

Which major investors are selling PepGen stock?

During the previous quarter, PEPG stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
In the last year, company insiders that have sold PepGen company stock include:
  1. Ra Capital Management, LP (Director)
  2. James G Mcarthur (CEO)
Learn More investors selling PepGen stock.

Which major investors are buying PepGen stock?

Within the last quarter, PEPG stock was purchased by institutional investors including:
  1. Sofinnova Investments Inc.
  2. Bank of New York Mellon Corp
  3. Marshall Wace LLP
  4. Renaissance Technologies LLC
  5. Rhumbline Advisers
  6. American Century Companies Inc.
  7. Point72 DIFC Ltd
  8. Point72 DIFC Ltd
In the last year, these company insiders have bought PepGen stock:
  1. Ra Capital Management, LP (Director)
  2. James G Mcarthur (CEO)
Learn More investors buying PepGen stock.